Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Regulatory
  • Trump nominates policy aide Overton to lead FDA
  • Regulatory

Trump nominates policy aide Overton to lead FDA

BioPharma Dive

Heidi Overton, a medical doctor and veteran of the America First think tank, currently serves as deputy director of the White House Domestic Policy Council.

Read full story

pharminent August 19, 2026 (Last updated: August 21, 2026)

BioPharma Dive

Heidi Overton, a medical doctor and veteran of the America First think tank, currently serves as deputy director of the White House Domestic Policy Council.

Read full story

Post navigation

Previous: Amylyx’s Avexitide Succeeds in Phase 3 Pivotal Study for Post-Bariatric Hypoglycemia
Next: Moderna and Merck’s Personalized Melanoma Vaccine Scores Historic Phase 3 Win

Related Stories

  • Regulatory

Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa

pharminent August 20, 2026
  • Regulatory

Lantheus Holdings’ Alzheimer’s radiodiagnostic secures FDA approval

pharminent August 17, 2026
  • Regulatory

BMS bags first approval for myeloma CELMoD Zenbexus

pharminent August 14, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.